Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03601780Phase 2Unknown
Phase 2 trial of ropivacaine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Postoperative pain at 48 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03601780.